Generic Drug Research Collaboration Opportunities

The FDA Office of Generic Drugs implements the GDUFA Regulatory Science Research Program by collaborating within FDA as well as externally through grants or contracts. 

Contracts

• FY26 BAA announcement with "Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science applications are accepted on a continuous basis (see FDABAA-26-00123) 

Grant Forecasts

• Center for Research on Complex Generics (U18) Clinical Trials Optional (FOR-FD-25-004)

Other Collaboration Opportunities

• The Center for Research on Complex Generics